NYSE: ABT
Abbott Laboratories Stock Forecast, Predictions & Price Target

Analyst price target for ABT

Based on 10 analysts offering 12 month price targets for Abbott Laboratories.
Min Forecast
$125.00-0.28%
Avg Forecast
$137.00+9.29%
Max Forecast
$146.00+16.47%

Should I buy or sell ABT stock?

Based on 11 analysts offering ratings for Abbott Laboratories.
Strong Buy
Strong Buy
6 analysts 54.55%
Buy
3 analysts 27.27%
Hold
2 analysts 18.18%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ABT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Anonymous
Morgan Stanley
Strong BuyMaintains$151.00+20.46%2022-01-27
Raymond James
Top 18%
83
BuyMaintains$143.00+14.08%2022-01-27
RBC Capital
Bottom 15%
15
BuyInitiates Coverage On$146.00+16.47%2021-12-10
Atlantic Equities
Bottom 38%
38
Strong BuyUpgrades$144.00+14.88%2021-10-27
Morgan Stanley
Bottom 15%
15
Strong BuyMaintains$146.00+16.47%2021-10-21
SVB Leerink
Bottom 3%
3
HoldMaintains$140.00+11.69%2021-10-21
Redburn Partners
Bottom 48%
48
HoldInitiates Coverage OnN/AN/A2021-10-14
BTIG
Top 3%
98
Strong BuyMaintains$136.00+8.50%2021-08-31
Credit Suisse
Top 27%
74
BuyMaintains$130.00+3.71%2021-07-23
Wells Fargo
Top 15%
86
Strong BuyMaintains$135.00+7.70%2021-07-12

1 of 2

Forecast return on equity

Is ABT forecast to generate an efficient return?
Company
32.93%
Industry
27.53%
Market
58.24%
ABT's Return on Equity is... subscribe to Premium to read more.
Forecast

Forecast return on assets

Is ABT forecast to generate an efficient return on assets?
Company
15.46%
Industry
14.48%
ABT is forecast to generate... subscribe to Premium to read more.
Forecast

ABT earnings per share forecast

What is ABT's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$4.79+17.98%
Avg 2 year Forecast
$5.18+27.59%
Avg 3 year Forecast
$5.89+45.07%
ABT's earnings are forecast to... subscribe to Premium to read more.
Forecast

ABT revenue forecast

What is ABT's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$39.8B-5.83%
Avg 2 year Forecast
$42.3B+0.03%
Avg 3 year Forecast
$47.4B+12.07%
ABT's revenue is forecast to... subscribe to Premium to read more.
Forecast

ABT earnings growth forecast

How is ABT forecast to perform vs Medical Devices companies and vs the US market?
Company
12.1%
Industry
20.76%
Market
18.83%
ABT's earnings are forecast to... subscribe to Premium to read more.
Forecast
ABT's earnings are forecast to... subscribe to Premium to read more.
Forecast
ABT's earnings are forecast to... subscribe to Premium to read more.
Forecast

ABT revenue growth forecast

How is ABT forecast to perform vs Medical Devices companies and vs the US market?
Company
2.82%
Industry
8.18%
Market
11.5%
ABT's revenues are forecast to... subscribe to Premium to read more.
Forecast
ABT's revenues are forecast to... subscribe to Premium to read more.
Forecast

Abbott Laboratories Stock Forecast FAQ

Is Abbott Laboratories Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NYSE: ABT) stock is to Strong Buy ABT stock.

Out of 11 analysts, 6 (54.55%) are recommending ABT as a Strong Buy, 3 (27.27%) are recommending ABT as a Buy, 2 (18.18%) are recommending ABT as a Hold, 0 (0%) are recommending ABT as a Sell, and 0 (0%) are recommending ABT as a Strong Sell.

What is ABT's earnings growth forecast for 2022-2024?

(NYSE: ABT) Abbott Laboratories's forecast annual earnings growth rate of 12.1% is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 20.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.83%.

Abbott Laboratories's earnings in 2022 is $7,244,000,000.On average, 5 Wall Street analysts forecast ABT's earnings for 2022 to be $8,470,094,582, with the lowest ABT earnings forecast at $8,310,948,754, and the highest ABT earnings forecast at $8,982,897,803. On average, 6 Wall Street analysts forecast ABT's earnings for 2023 to be $9,159,726,499, with the lowest ABT earnings forecast at $8,947,532,063, and the highest ABT earnings forecast at $9,478,018,154.

In 2024, ABT is forecast to generate $10,415,210,247 in earnings, with the lowest earnings forecast at $10,415,210,247 and the highest earnings forecast at $10,415,210,247.

What is ABT's revenue growth forecast for 2022-2024?

(NYSE: ABT) Abbott Laboratories's forecast annual revenue growth rate of 2.82% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.18%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.5%.

Abbott Laboratories's revenue in 2022 is $42,308,000,000.On average, 6 Wall Street analysts forecast ABT's revenue for 2022 to be $70,449,893,206,483, with the lowest ABT revenue forecast at $69,058,679,287,326, and the highest ABT revenue forecast at $72,386,188,656,981. On average, 6 Wall Street analysts forecast ABT's revenue for 2023 to be $74,834,206,905,152, with the lowest ABT revenue forecast at $72,556,262,497,660, and the highest ABT revenue forecast at $78,250,234,952,188.

In 2024, ABT is forecast to generate $83,839,790,061,197 in revenue, with the lowest revenue forecast at $83,839,790,061,197 and the highest revenue forecast at $83,839,790,061,197.

What is ABT's forecast return on assets (ROA) for 2022-2025?

(NYSE: ABT) forecast ROA is 15.46%, which is higher than the forecast US Medical Devices industry average of 14.48%.

What is ABT's Price Target?

According to 10 Wall Street analysts that have issued a 1 year ABT price target, the average ABT price target is $137.00, with the highest ABT stock price forecast at $146.00 and the lowest ABT stock price forecast at $125.00.

On average, Wall Street analysts predict that Abbott Laboratories's share price could reach $137.00 by Jan 27, 2023. The average Abbott Laboratories stock price prediction forecasts a potential upside of 9.29% from the current ABT share price of $125.35.

What is ABT's Earnings Per Share (EPS) forecast for 2022-2024?

(NYSE: ABT) Abbott Laboratories's current Earnings Per Share (EPS) is $4.06. On average, analysts forecast that ABT's EPS will be $4.79 for 2022, with the lowest EPS forecast at $4.70, and the highest EPS forecast at $5.08. On average, analysts forecast that ABT's EPS will be $5.18 for 2023, with the lowest EPS forecast at $5.06, and the highest EPS forecast at $5.36. In 2024, ABT's EPS is forecast to hit $5.89 (min: $5.89, max: $5.89).

What is ABT's forecast return on equity (ROE) for 2022-2025?

(NYSE: ABT) forecast ROE is 32.93%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.